Foundation Medicine Inc.

09/03/2024 | Press release | Distributed by Public on 09/03/2024 11:04

U.S. Food and Drug Administration Approves FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for Lynparza® (olaparib) in Combination with Abiraterone for[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.